Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH CLL 2020 | Key questions about the future of CLL

Florence Cymbalista • 17 Nov 2020
ESH CLL 2020
Chronic Lymphocytic Leukemia Leukemia

Florence Cymbalista, MD, PhD, Avicenne Hospital, Bobigny, France, poses key questions about the future of chronic lymphocytic leukemia (CLL) treatment, including how treatments should be sequenced, as well as a greater understanding of resistance mechanisms. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Florence Cymbalista

2:30
Towards strategies to optimize outcomes in CLL
Florence Cymbalista • 7 Oct 2022
2:07
Moving towards time-limited treatment in frontline CLL
Florence Cymbalista • 7 Oct 2022
2:27
The importance of TP53 & IGHV testing before treatment initiation in CLL
Florence Cymbalista • 7 Oct 2022
1:33
Challenges in interpreting the results of genomic tests in CLL
Florence Cymbalista • 7 Oct 2022

Related Videos

1:25
The role of the bone marrow microenvironment in hematological malignancies
Manja Wobus • 17 Apr 2024
2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals